FDA Panel Backs Allergan ' s Drug for Frequent Nightly Urination FDA Panel Backs Allergan ' s Drug for Frequent Nightly Urination

The benefits associated with Allergan Plc ' s experimental drug to treat frequent nightly urination outweigh the risks for certain patients, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.Reuters Health Information
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Pharmacist News Source Type: news